Singapore markets close in 2 hours 59 minutes

Phathom Pharmaceuticals, Inc. (PHAT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.12+0.06 (+0.66%)
At close: 04:00PM EDT
9.12 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 533.74M
Enterprise value 291.38M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)685.86
Price/book (mrq)N/A
Enterprise value/revenue 427.24
Enterprise value/EBITDA -1.83

Trading information

Stock price history

Beta (5Y monthly) 0.63
52-week change 3-10.76%
S&P500 52-week change 322.64%
52-week high 317.02
52-week low 36.07
50-day moving average 39.67
200-day moving average 310.20

Share statistics

Avg vol (3-month) 3885.48k
Avg vol (10-day) 3614.29k
Shares outstanding 558.52M
Implied shares outstanding 658.52M
Float 843.23M
% held by insiders 18.80%
% held by institutions 188.60%
Shares short (28 Mar 2024) 410.65M
Short ratio (28 Mar 2024) 412.09
Short % of float (28 Mar 2024) 426.13%
Short % of shares outstanding (28 Mar 2024) 418.21%
Shares short (prior month 29 Feb 2024) 48.67M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-10,245.60%

Management effectiveness

Return on assets (ttm)-36.14%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)682k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -166.74M
Net income avi to common (ttm)-201.59M
Diluted EPS (ttm)-3.93
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)381.39M
Total cash per share (mrq)6.52
Total debt (mrq)445.96M
Total debt/equity (mrq)N/A
Current ratio (mrq)10.25
Book value per share (mrq)-1.25

Cash flow statement

Operating cash flow (ttm)-137.58M
Levered free cash flow (ttm)-90.45M